Fibrotic interstitial lung diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Japanese patients 18 years of age or older at the time of consent 2) Patients diagnosed with interstitial lung disease who have at least one of the following findings on HRCT: honey comb change, traction bronchiectasis, or reticulopapillary shadows. 3) Patients who have been fully informed of the study and who have given their free and voluntary written consent based on their full understanding of the study.
Exclusion criteria
Exclusion criteria: 1) Patients for whom respiratory function tests cannot be performed 2) Patients with advanced cancer comorbidities 3) Patients on dose adjustment of corticosteroids 4) Patients who are judged by the principal investigator or subinvestigator to be unsuitable for the safe conduct of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of patients diagnosed with cachexia | — |
Countries
Japan
Contacts
Chiba University Hospital Department of Respirology